Matinas Biopharma Hl
(MTNB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 1,577 | 1,837 | 1,946 | 8,471 | 4,381 |
| Operating Income | -1,577 | -1,837 | -1,946 | -8,471 | -4,381 |
| Other Income | 45 | -3,408 | 290 | -42 | 106 |
| Pre-tax Income | -1,532 | -5,245 | -1,656 | -8,513 | -4,275 |
| Net Income Continuous | -1,532 | -5,245 | -1,656 | -8,433 | -4,275 |
| Net Income | $-1,532 | $-5,245 | $-1,656 | $-8,433 | $-4,275 |
| EPS Basic Total Ops | -0.40 | -1.03 | -0.33 | -1.64 | -0.85 |
| EPS Basic Continuous Ops | -0.28 | -1.03 | -0.33 | -1.65 | -0.85 |
| EPS Diluted Total Ops | -0.40 | -1.03 | -0.33 | -1.64 | -0.85 |
| EPS Diluted Continuous Ops | -0.28 | -1.03 | -0.33 | -1.65 | -0.85 |
| EPS Diluted Before Non-Recurring Items | -0.40 | -1.03 | -0.33 | -1.68 | -0.85 |
| EBITDA(a) | $-1,466 | $-1,715 | $-1,818 | $-8,225 | $-4,134 |